Standout Papers
Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Primary Prevention of Ischemic Stroke
2006
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
2001
Regional and Racial Differences in Response to Antihypertensive Medication Use in a Randomized Controlled Trial of Men With Hypertension in the United States
2000
Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice
2005
Cardiovascular prevention and blood pressure reduction
2003
Risk factors associated with alterations in carotid intima—media thickness in hypertension
1998
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
1999
Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial
2001
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
1999
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
2003
Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy
2002
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
2005
A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study
2001
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Global burden of hypertension: analysis of worldwide data
2005 Standout
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
2003
Elevated systolic blood pressure as a cardiovascular risk factor
2000
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials
2013
Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic Hypertension
2002
Hypertension in the Very Elderly Trial (HYVET)
2001
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
The metabolic syndrome
2010 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
1999
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial
2005
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
2000
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Reliable and unbiased assessment of the effects of calcium antagonists
1997
Human health effects of air pollution
2007 Standout
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
The changing landscape of atherosclerosis
2021 StandoutNature
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Time Trends in High Blood Pressure Control and the Use of Antihypertensive Medications in Older Adults
2002
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
The Study on Cognition and Prognosis in the Elderly (SCOPE)
2003
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
2005
Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
2004
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials
1999
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial
2001
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
2004
A Selective, Nontoxic, OFF–ON Fluorescent Molecular Sensor Based on 8‐Hydroxyquinoline for Probing Cd2+ in Living Cells
2009
Treatment of Isolated Systolic Hypertension: The SHELL Study Results
2003
Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension
2001
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension
2004
The metabolic syndrome
2005 Standout
Prevalence, awareness, treatment, and control of hypertension in Greece The Didima study
1999
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial
2005
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials
2000
Why is hypertension so frequently uncontrolled in secondary prevention?
2003
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
1998
Prevention of Heart Failure
2008
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Cadmium and cellular signaling cascades: To be or not to be?
2009
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
2000
Effects of amlodipine and lisinopril on intima–media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial)
2004
Diastolic Heart Failure in the Elderly
2007
Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited
1999
Effects of blood pressure lowering on outcome incidence in hypertension
2014
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium
2002
Risk factor thresholds: their existence under scrutiny
2002
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension
1999
Pulse Pressure Not Mean Pressure Determines Cardiovascular Risk in Older Hypertensive Patients
2000
Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
2001
Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups
2002
Subgroup and Per-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly
1998
Chinese Trial on Isolated Systolic Hypertension in the Elderly
2000
Diastolic Heart Failure in the Elderly
2007
Stroke is More Common than Myocardial Infarction in Hypertension: Analysis based on 11 Major Randomized Intervention Trials
2001
Alzheimer's Disease
2010 Standout
Effects of ACE Inhibitors, Calcium Antagonists, and Other Blood Pressure lowering Drugs
2001
Prognosis of “Masked” Hypertension and “White-Coat” Hypertension Detected by 24-h Ambulatory Blood Pressure Monitoring
2005
Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Predictive Value of Clinic and Ambulatory Heart Rate for Mortality in Elderly Subjects With Systolic Hypertension
2002
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure
2012
Ace inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension
2001
Task Force II: Blood pressure measurement and cardiovacular outcome
2001
On-Treatment Diastolic Blood Pressure and Prognosis in Systolic Hypertension
2007
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
1998
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents
2003
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
2000
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
2014
Spontaneous Intracerebral Hemorrhage
2001 Standout
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk
2003
Cardiovascular Prognosis of "Masked Hypertension" Detected by Blood Pressure Self-measurement in Elderly Treated Hypertensive Patients
2004
Blood Pressure and Survival in the Oldest Old
2007
Adherence to Medication
2005 Standout
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
2008
The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
2002
Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention
2005
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity
2020
Primary Prevention of Ischemic Stroke
2001
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Target intervention against multiple‐risk markers to reduce cardiovascular disease in patients with type 2 diabetes
2004
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design
1998
The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, Patient Characteristics, and Blood Pressure during the First 12 Months
2005
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?
2001
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age)
2002
Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly
2010
Isolated Ambulatory Hypertension Predicts Cardiovascular Morbidity in Elderly Men
2003
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
2006
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
2001
Intensive Integrated Therapy of Type 2 Diabetes
2004
Differential Control of Systolic and Diastolic Blood Pressure
2000
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
1999
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
2006
Hypertension and Its Treatment in Postmenopausal Women
2000
Role of Diuretics in the Prevention of Heart Failure
2006
Primary Prevention of Ischemic Stroke
2001
Blood Pressure Lowering in Type 2 Diabetes
2015
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2001
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Management of High Blood Pressure in Blacks
2010
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
2000
Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
2003
Health outcomes associated with various antihypertensive therapies used as first-line agents
2003
Blood Pressure and Stroke
2004
Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives
2001
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
2006
ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension
2005
Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril
2006
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
2004
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of Hilde Celis being referenced
The older hypertensive. Assessment and treatment.
1993
Cardiovascular Risk In White-coat and Sustained Hypertensive Patients
2002
For how many days should blood pressure be measured at home in older patients before steady levels are obtained?
1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Reference Values for Self-recorded Blood Pressure
1998
White-coat hypertension: a clinical review
2004
Environmental exposure to cadmium and risk of cancer: a prospective population-based study
2006
Prognostic significance of various characteristics of out-of-the-office blood pressure
2004
Conventional and ambulatory measurements of blood pressure in old patients with isolated systolic hypertension: baseline observations in the Syst-Eur trial.
1998
Prognostic Significance of Electrocardiographic Voltages and Their Serial Changes in Elderly With Systolic Hypertension
2004
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial
2004
The International Database of Self-Recorded Blood Pressures in normotensive and untreated hypertensive subjects
1999